InvestorsHub Logo
Followers 27
Posts 744
Boards Moderated 0
Alias Born 07/12/2012

Re: None

Friday, 07/14/2017 11:28:03 AM

Friday, July 14, 2017 11:28:03 AM

Post# of 345969
Ronin's move VALIDATES PS science

They're not just in this for Avid.

No way.

They want a halt on PPHM-funded Bavi studies. OK, who cares.

What I care about is NCCN. That's where the toast gets buttered.

NCCN will combine Bavi and Keytruda. This is what we want! If (when) this trial show tripling of the anti-PD1 responder footprint, Big Pharm goes berserk.

Maybe they already know enough now. Maybe a deal if forthcoming. Soon.

Of course, we'll keep a sharp eye out for a "Ronin Ripoff."

But hard to deny we haven't been ripped off pretty badly already.

Best,

Joe Six Pack
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News